Komodo Health and NCQA Collaborate to Accelerate the Future of Healthcare Quality Measurement
Developing new healthcare quality measures traditionally meant assembling fragmented datasets from multiple sources, creating long development and testing cycles; NCQA wanted to modernize measure development to keep pace with clinical evidence and real-world care. Komodo Health and NCQA entered a multi-year strategic collaboration using Komodo's Healthcare Map (de-identified data covering 330+ million patient journeys) and Marmot, its healthcare-native AI analytics platform, to test a new HEDIS measure — Follow-Up After Positive Colorectal Cancer Non-Invasive Screening Test (COF-E) — across Medicare Advantage, Medicaid and commercial populations from a single longitudinal data source. Testing time dropped from two-to-three months to about one month, and the COF-E measure is slated for implementation in Measurement Year 2027.
Komodo Health runs the 'Healthcare Map,' one of the largest linked longitudinal patient-record graphs sold commercially into pharma for real-world analytics.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Komodo Health on its own site — read the original case study on komodohealth.com ↗
Related use cases
- 01Komodo Expands Strategic Partnership With Alnylam to Scale AI-Powered Intelligence Platform
- 02Komodo Health and ZERO Prostate Cancer Announce Partnership to Close Gaps in Prostate Cancer Screening and Care
- 03Customer Stories — Christopher Blanchette, VP Clinical Data Science & Evidence, Novo Nordisk
- 04Customer Stories — Ritu Saxena, Director, Pharmaceutical Commercial AI Agents, Merck
- 05Customer Stories — Taylor Woodroof, Director of Data Analytics, Pharmacy Services, Fairview Health Services
- 06Customer Stories — Anjee Davis, CEO, FightCRC